Alnylam Pharmaceuticals was up 15.4% in early Thursday trading, making it the top Nasdaq 100 performer for the day. Despite the jump, the stock remains down about 6.1% year to date. The move suggests a near-term positive repricing, though the article does not cite a specific fundamental catalyst.
Alnylam Pharmaceuticals was up 15.4% in early Thursday trading, making it the top Nasdaq 100 performer for the day. Despite the jump, the stock remains down about 6.1% year to date. The move suggests a near-term positive repricing, though the article does not cite a specific fundamental catalyst.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
